Publication | Closed Access

Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 2: Variation of the 2- and 6-pyridazinone substituents

Medicinal ChemistryBiochemistryViral Polymerase StructureMedicineNatural SciencesAntiviral Drug DevelopmentAntiviral TherapyAntiviral DrugPharmacologyAntiviral CompoundPharmaceutical ChemistryDrug Discovery